Ten of 105 (9.5%) probably pathogenic POLE ED variant heterozygotes developed duodenal cancer (DC; median age 55) and 16 (15%) developed one or more duodenal adenomas (DAs; median age 43). Here, POLE is linked to duodenum cancer.